EVENTIDE ASSET MANAGEMENT, LLC

Q2 2021 13F-HR Holdings

Location
Boston, MA
Holdings as of
6/30/2021
Date filed
8/16/2021
Form type
13F-HR
Num holdings
152
Total value ($000)
$7,444,271
Net value change ($000)
+696,300 (10.3%)
New positions
15
Sold out positions
16
Turnover %
5.0%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q1 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ZYMEWORKS INC 66,886 151.5%
CRWD 61,321 37.7%
GNRC 56,052 74.7%
Biohaven Pharmaceutical Holding Co Ltd. 55,542 40.3%
ARGX 41,323 70.1%
NCNO 39,697 NEW
SHLS 37,731 276.3%
MTD 36,122 30.3%
TTD 34,470 19.3%
IDXX 34,138 29.1%
Top Reduces (Value $000, Stocks/ETFs)
SRPT -51,959 -100.0%
PRAX -41,683 -38.1%
VRSK -37,843 -50.4%
SNDX -33,041 -73.3%
Karuna Therapeutics, Inc. -31,488 -27.0%
KURA -31,051 -67.9%
PLRX -25,239 -26.0%
OKTA -23,806 -100.0%
KALA -23,253 -100.0%
NBIX -23,227 -50.4%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type